PD-L1 POSITIVE
Clinical trials for PD-L1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PD-L1 POSITIVE trials appear
Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo takes on tough breast cancer
Disease control Not yet recruitingThis phase 2 trial tests a combination of two drugs—Sacituzumab Tirumotecan and Toripalimab—as a first treatment for people with a specific type of advanced triple-negative breast cancer that is PD-L1 positive. The study aims to see if the combo shrinks tumors and improves surviv…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug cocktail aims to shrink Hard-to-Treat breast tumors
Disease control Not yet recruitingThis Phase 2 trial is testing a combination of two drugs—Sacituzumab tirumotecan and Tagitanlimab—in people with a specific type of advanced breast cancer called PD-L1-positive triple negative breast cancer. The study will enroll 47 participants whose cancer has already been trea…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC